Alprazolam and Hepatitis toxic - a phase IV clinical study of FDA data

Summary:

Hepatitis toxic is reported as a side effect among people who take Alprazolam (alprazolam), especially for people who are female, 60+ old, also take Atenolol, and have Atrial fibrillation/flutter.

The phase IV clinical study analyzes which people have Hepatitis toxic when taking Alprazolam. It is created by eHealthMe based on reports of 132,238 people who have side effects when taking Alprazolam from the FDA, and is updated regularly.

What is Alprazolam?

Alprazolam has active ingredients of alprazolam. It is often used in stress and anxiety. eHealthMe is studying from 134,864 Alprazolam users. Check the latest studies of Alprazolam.

What is Hepatitis toxic?

Hepatitis toxic is found to be associated with 281 drugs and 523 conditions by eHealthMe. Check the latest studies of Hepatitis toxic.

On Jul, 17, 2026

132,238 people reported to have side effects when taking Alprazolam.
Among them, 23 people (0.02%) have Hepatitis toxic.

Among these 23 people:

What is the gender of people who have Hepatitis toxic when taking Alprazolam? *

female: 82.61 %
male: 17.39 %

What is the age of people who have Hepatitis toxic when taking Alprazolam? *

What are other drugs people take besides Alprazolam? *

What are other side effects people have besides Hepatitis toxic? *

Withdrawal Syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance): 4 people, 17.39%
Sopor (sleep): 4 people, 17.39%
Respiratory Distress (difficulty in breathing): 4 people, 17.39%
Myocarditis (inflammation of heart muscle myocardium): 4 people, 17.39%
Hypokinesia (decreased bodily movement): 4 people, 17.39%
Hepatitis C: 4 people, 17.39%
Consciousness - Decreased: 4 people, 17.39%
Bradyphrenia (neurological term referring to the slowness of thought common to many disorders of the brain): 4 people, 17.39%
Self Injurious Behavior: 2 people, 8.70%
Multiple Drug Overdose Intentional: 2 people, 8.70%

What are the existing conditions these people have? *

Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 4 people, 17.39%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 2 people, 8.70%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 8.70%
Multiple Sclerosis Relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 4.35%
Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 4.35%
High Blood Pressure: 1 person, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Alprazolam and have Hepatitis toxic?

- Check whether Hepatitis toxic is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Alprazolam:

Alprazolam (134,864 reports)

Hepatitis toxic treatments and more:

Hepatitis toxic (3,159 reports)

Browse all side effects of Alprazolam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hepatitis toxic:

Hepatitis toxic (281 drugs)

Browse all the conditions that are associated with Hepatitis toxic:

Hepatitis toxic (523 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on alprazolam (the active ingredients of Alprazolam) and Alprazolam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.